Phenylephrine Hemorrhoidal Suppository
NDC Package 13709-330-01
Package Information
Phenylephrine Hemorrhoidal (hemorrhoidal suppositories) suppositories is • Adults: when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. This formulation utilizes a suppository delivery system. Marketed by Neilmed Pharmaceuticals Inc., this product is identified by NDC 13709-330 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 2715398 - phenylephrine hydrochloride 0.25 % Rectal Suppository
- RxCUI: 2715398 - phenylephrine hydrochloride 0.0025 MG/MG Rectal Suppository
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 13709 - Neilmed Pharmaceuticals Inc.
- 13709-330 - Phenylephrine Hemorrhoidal
- 13709-330-01 - 30 BLISTER PACK in 1 CARTON / 2 g in 1 BLISTER PACK
- 13709-330 - Phenylephrine Hemorrhoidal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (13709-330). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 13709-330-01 identifies a specific commercial package of 30 blister pack in 1 carton / 2 g in 1 blister pack of Phenylephrine Hemorrhoidal, a human over the counter drug labeled by Neilmed Pharmaceuticals Inc.. This suppository is formulated for rectal use and contains phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Neilmed Pharmaceuticals Inc. on May 23, 2025. The current certification is valid through December 31, 2026.
How is this Neilmed Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 13709033001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.